Amgen Announces Appointment Of Fred Hassan To Board Of Directors

Go back to Amgen Announces Appointment Of Fred Hassan To Board Of Directors

Piper Jaffray Raises Price Target on Amgen (AMGN) to $200 Following 2Q EPS Beat

July 31, 2015 10:47 AM EDT

Piper Jaffray reiterated an Overweight rating on Amgen (NASDAQ: AMGN), and raised the price target to $200.00 (from $192.00), following 2Q earnings results. Total revenue of $5.37B was ahead of consensus by $64M. EPS of $2.57 beat estimates by $0.16 aided by lower than expected R&D.... More